Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Pavot

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Vaccine|August 11, 2019
Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in miceGuha Asthagiri Arunkumar, Meagan McMahon, Vincent Pavot, et al.
Nanomedicine (London, England)|December 23, 2014
Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine deliveryVincent Pavot, Morgane Berthet, Julien Rességuier, et al.
Pharmaceutical Research|September 25, 2014
Preparation and in vitro evaluation of imiquimod loaded polylactide-based micelles as potential vaccine adjuvantsGloria Jiménez-Sánchez, Vincent Pavot, Christelle Chane-Haong, et al.
NPJ Vaccines|March 21, 2020
An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaquesValérie Lecouturier, Vincent Pavot, Catherine Berry, et al.
NPJ Vaccines|December 8, 2025
Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platformsAndrea-Clemencia Pineda-Peña, Kohei Hasegawa, Vincent Pavot, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2014
Particle-based transcutaneous administration of HIV-1 p24 protein to human skin explants and targeting of epidermal antigen presenting cellsFiorenza Rancan, Sarah Amselgruber, Sabrina Hadam, et al.
Vaccine|September 22, 2014
Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responsesNúria Climent, Séverine Munier, Núria Piqué, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 14, 2014
Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicityVincent Pavot, Nicolas Rochereau, Julien Rességuier, et al.
Biomaterials|November 6, 2015
Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligandsVincent Pavot, Nuria Climent, Nicolas Rochereau, et al.
Frontiers in Immunology|September 10, 2019
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus ChallengeMeagan McMahon, Guha Asthagiri Arunkumar, Wen-Chun Liu, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Vaccine|August 11, 2019
Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in miceGuha Asthagiri Arunkumar, Meagan McMahon, Vincent Pavot, et al.
Nanomedicine (London, England)|December 23, 2014
Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine deliveryVincent Pavot, Morgane Berthet, Julien Rességuier, et al.
Pharmaceutical Research|September 25, 2014
Preparation and in vitro evaluation of imiquimod loaded polylactide-based micelles as potential vaccine adjuvantsGloria Jiménez-Sánchez, Vincent Pavot, Christelle Chane-Haong, et al.
NPJ Vaccines|March 21, 2020
An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaquesValérie Lecouturier, Vincent Pavot, Catherine Berry, et al.
NPJ Vaccines|December 8, 2025
Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platformsAndrea-Clemencia Pineda-Peña, Kohei Hasegawa, Vincent Pavot, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2014
Particle-based transcutaneous administration of HIV-1 p24 protein to human skin explants and targeting of epidermal antigen presenting cellsFiorenza Rancan, Sarah Amselgruber, Sabrina Hadam, et al.
Vaccine|September 22, 2014
Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responsesNúria Climent, Séverine Munier, Núria Piqué, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 14, 2014
Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicityVincent Pavot, Nicolas Rochereau, Julien Rességuier, et al.
Biomaterials|November 6, 2015
Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligandsVincent Pavot, Nuria Climent, Nicolas Rochereau, et al.
Frontiers in Immunology|September 10, 2019
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus ChallengeMeagan McMahon, Guha Asthagiri Arunkumar, Wen-Chun Liu, et al.
Pageof 4